218 related articles for article (PubMed ID: 35903358)
1. The Role of ERBB Signaling Pathway-Related Genes in Kidney Renal Clear Cell Carcinoma and Establishing a Prognostic Risk Assessment Model for Patients.
Wang Z; Li J; Zhang P; Zhao L; Huang B; Xu Y; Wu G; Xia Q
Front Genet; 2022; 13():862210. PubMed ID: 35903358
[No Abstract] [Full Text] [Related]
2. Establishment of a new prognostic risk model of MAPK pathway-related molecules in kidney renal clear cell carcinoma based on genomes and transcriptomes analysis.
Zhang P; Li J; Wang Z; Zhao L; Qiu J; Xu Y; Wu G; Xia Q
Front Oncol; 2023; 13():1077309. PubMed ID: 36969076
[TBL] [Abstract][Full Text] [Related]
3. Development of a Novel Sphingolipid Signaling Pathway-Related Risk Assessment Model to Predict Prognosis in Kidney Renal Clear Cell Carcinoma.
Sun Y; Xu Y; Che X; Wu G
Front Cell Dev Biol; 2022; 10():881490. PubMed ID: 35846357
[TBL] [Abstract][Full Text] [Related]
4. Identifying the Potential Role and Prognostic Value of the Platelet-Derived Growth Factor Pathway in Kidney Renal Clear Cell Carcinoma.
Xin S; Sun X; Jin L; Zhou Z; Liu X; Li W; Mei W; Zhang J; Zhang B; Yao X; Zhou L; Ye L
J Oncol; 2022; 2022():9498010. PubMed ID: 35342405
[TBL] [Abstract][Full Text] [Related]
5. Development and Validation of Nine-RNA Binding Protein Signature Predicting Overall Survival for Kidney Renal Clear Cell Carcinoma.
Zhong W; Huang C; Lin J; Zhu M; Zhong H; Chiang MH; Chiang HS; Hui MS; Lin Y; Huang J
Front Genet; 2020; 11():568192. PubMed ID: 33133154
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the basement membrane in kidney renal clear cell carcinoma to guide clinical therapy.
Xiong X; Chen C; Yang J; Ma L; Wang X; Zhang W; Yuan Y; Peng M; Li L; Luo P
Front Oncol; 2022; 12():1024956. PubMed ID: 36439501
[TBL] [Abstract][Full Text] [Related]
7. A New Prognostic Risk Model Based on PPAR Pathway-Related Genes in Kidney Renal Clear Cell Carcinoma.
Xu Y; Li X; Han Y; Wang Z; Han C; Ruan N; Li J; Yu X; Xia Q; Wu G
PPAR Res; 2020; 2020():6937475. PubMed ID: 33029112
[TBL] [Abstract][Full Text] [Related]
8. A new prognostic risk model based on autophagy-related genes in kidney renal clear cell carcinoma.
Wu G; Xu Y; Zhang H; Ruan Z; Zhang P; Wang Z; Gao H; Che X; Xia Q; Chen F
Bioengineered; 2021 Dec; 12(1):7805-7819. PubMed ID: 34636718
[TBL] [Abstract][Full Text] [Related]
9. Immune-pyroptosis-related genes predict the prognosis of kidney renal clear cell carcinoma.
Zhang M; Liu YF; Gao Y; Zhao C; Chen M; Pan KH
Transl Oncol; 2023 Aug; 34():101693. PubMed ID: 37315507
[TBL] [Abstract][Full Text] [Related]
10. Construction of a prognostic prediction model for renal clear cell carcinoma combining clinical traits.
Weng Y; Ning P
Sci Rep; 2023 Feb; 13(1):3358. PubMed ID: 36849551
[TBL] [Abstract][Full Text] [Related]
11. A 9-gene prognostic signature for kidney renal clear cell carcinoma overall survival based on co-expression and regression analyses.
Zhu W; Ding M; Chang J; Liao H; Xiao G; Wang Q
Chem Biol Drug Des; 2023 Feb; 101(2):422-437. PubMed ID: 36053927
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic and prognostic role of basic leucine zipper transcription factor in kidney renal clear cell carcinoma.
Zhang H; Zhang H; Hu Y; Huang B; Chen J; Chen L
Transl Androl Urol; 2022 Feb; 11(2):238-252. PubMed ID: 35280662
[TBL] [Abstract][Full Text] [Related]
13. Identification of Survival Risk and Immune-Related Characteristics of Kidney Renal Clear Cell Carcinoma.
Wu X; Liang Y; Chen X; Long X; Xu W; Liu L; Wang B; Zou X
J Immunol Res; 2022; 2022():6149369. PubMed ID: 35832648
[TBL] [Abstract][Full Text] [Related]
14. Construction and validation of an autophagy-related long noncoding RNA signature for prognosis prediction in kidney renal clear cell carcinoma patients.
Yu J; Mao W; Xu B; Chen M
Cancer Med; 2021 Apr; 10(7):2359-2369. PubMed ID: 33650306
[TBL] [Abstract][Full Text] [Related]
15. Bioinformatics analysis reveals biomarkers with cancer stem cell characteristics in kidney renal clear cell carcinoma.
Zhang Z; Xiong X; Zhang R; Xiong G; Yu C; Xu L
Transl Androl Urol; 2021 Aug; 10(8):3501-3514. PubMed ID: 34532274
[TBL] [Abstract][Full Text] [Related]
16. Identification of small molecule drugs and development of a novel autophagy-related prognostic signature for kidney renal clear cell carcinoma.
Xing Q; Ji C; Zhu B; Cong R; Wang Y
Cancer Med; 2020 Oct; 9(19):7034-7051. PubMed ID: 32780567
[TBL] [Abstract][Full Text] [Related]
17. Identification of an m6A-Related lncRNA Signature for Predicting the Prognosis in Patients With Kidney Renal Clear Cell Carcinoma.
Yu J; Mao W; Sun S; Hu Q; Wang C; Xu Z; Liu R; Chen S; Xu B; Chen M
Front Oncol; 2021; 11():663263. PubMed ID: 34123820
[TBL] [Abstract][Full Text] [Related]
18. Angiogenesis Pathway in Kidney Renal Clear Cell Carcinoma and Its Prognostic Value for Cancer Risk Prediction.
Che X; Su W; Li X; Liu N; Wang Q; Wu G
Front Med (Lausanne); 2021; 8():731214. PubMed ID: 34778292
[TBL] [Abstract][Full Text] [Related]
19. A polyamine metabolism risk signature for predicting the prognosis and immune therapeutic response of kidney cancer.
Li B; Kong Z; Liu Y; Xu B; Liu X; Li S; Zhang Z
Transl Cancer Res; 2023 Oct; 12(10):2477-2492. PubMed ID: 37969387
[TBL] [Abstract][Full Text] [Related]
20. Systematic analysis of alternative splicing signature unveils prognostic predictor for kidney renal clear cell carcinoma.
Song J; Liu YD; Su J; Yuan D; Sun F; Zhu J
J Cell Physiol; 2019 Dec; 234(12):22753-22764. PubMed ID: 31140607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]